Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1232564

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1232564

Global Clinical Next Generation Sequencing (NGS) Market Insights, Forecast to 2029

PUBLISHED:
PAGES: 111 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Clinical Next Generation Sequencing (NGS) Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Sequencing by Synthesis (SBS)
    • 1.2.3 Nanopore Sequencing
    • 1.2.4 Single-Molecule Real-Time (SMRT) Sequencing
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Diagnostics
    • 1.3.3 Drug Discovery & Designing
    • 1.3.4 Medical Research
    • 1.3.5 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Clinical Next Generation Sequencing (NGS) Market Perspective (2018-2029)
  • 2.2 Global Clinical Next Generation Sequencing (NGS) Growth Trends by Region
    • 2.2.1 Clinical Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Clinical Next Generation Sequencing (NGS) Historic Market Size by Region (2018-2023)
    • 2.2.3 Clinical Next Generation Sequencing (NGS) Forecasted Market Size by Region (2024-2029)
  • 2.3 Clinical Next Generation Sequencing (NGS) Market Dynamics
    • 2.3.1 Clinical Next Generation Sequencing (NGS) Industry Trends
    • 2.3.2 Clinical Next Generation Sequencing (NGS) Market Drivers
    • 2.3.3 Clinical Next Generation Sequencing (NGS) Market Challenges
    • 2.3.4 Clinical Next Generation Sequencing (NGS) Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Clinical Next Generation Sequencing (NGS) by Players
    • 3.1.1 Global Clinical Next Generation Sequencing (NGS) Revenue by Players (2018-2023)
    • 3.1.2 Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Players (2018-2023)
  • 3.2 Global Clinical Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Clinical Next Generation Sequencing (NGS), Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Clinical Next Generation Sequencing (NGS) Market Concentration Ratio
    • 3.4.1 Global Clinical Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Clinical Next Generation Sequencing (NGS) Revenue in 2022
  • 3.5 Global Key Players of Clinical Next Generation Sequencing (NGS) Head office and Area Served
  • 3.6 Global Key Players of Clinical Next Generation Sequencing (NGS), Product and Application
  • 3.7 Global Key Players of Clinical Next Generation Sequencing (NGS), Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Clinical Next Generation Sequencing (NGS) Breakdown Data by Type

  • 4.1 Global Clinical Next Generation Sequencing (NGS) Historic Market Size by Type (2018-2023)
  • 4.2 Global Clinical Next Generation Sequencing (NGS) Forecasted Market Size by Type (2024-2029)

5 Clinical Next Generation Sequencing (NGS) Breakdown Data by Application

  • 5.1 Global Clinical Next Generation Sequencing (NGS) Historic Market Size by Application (2018-2023)
  • 5.2 Global Clinical Next Generation Sequencing (NGS) Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 6.2 North America Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 6.2.1 North America Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 6.2.2 North America Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 6.2.3 North America Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 6.3 North America Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 6.3.1 North America Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 6.3.2 North America Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 6.3.3 North America Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • 6.4 North America Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 6.4.1 North America Clinical Next Generation Sequencing (NGS) Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
    • 6.4.3 North America Clinical Next Generation Sequencing (NGS) Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 7.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 7.2.1 Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 7.2.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 7.2.3 Europe Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 7.3 Europe Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 7.3.1 Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 7.3.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 7.3.3 Europe Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • 7.4 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 7.4.1 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
    • 7.4.3 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 8.2 China Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 8.2.1 China Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 8.2.2 China Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 8.2.3 China Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 8.3 China Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 8.3.1 China Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 8.3.2 China Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 8.3.3 China Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 9.2 Asia Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 9.2.1 Asia Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 9.2.2 Asia Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 9.2.3 Asia Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 9.3 Asia Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 9.3.1 Asia Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 9.3.2 Asia Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 9.3.3 Asia Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • 9.4 Asia Clinical Next Generation Sequencing (NGS) Market Size by Region
    • 9.4.1 Asia Clinical Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023)
    • 9.4.3 Asia Clinical Next Generation Sequencing (NGS) Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Agilent Technologies
    • 11.1.1 Agilent Technologies Company Details
    • 11.1.2 Agilent Technologies Business Overview
    • 11.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Introduction
    • 11.1.4 Agilent Technologies Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.1.5 Agilent Technologies Recent Developments
  • 11.2 Illumina
    • 11.2.1 Illumina Company Details
    • 11.2.2 Illumina Business Overview
    • 11.2.3 Illumina Clinical Next Generation Sequencing (NGS) Introduction
    • 11.2.4 Illumina Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.2.5 Illumina Recent Developments
  • 11.3 Thermo Fisher Scientific
    • 11.3.1 Thermo Fisher Scientific Company Details
    • 11.3.2 Thermo Fisher Scientific Business Overview
    • 11.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Introduction
    • 11.3.4 Thermo Fisher Scientific Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.3.5 Thermo Fisher Scientific Recent Developments
  • 11.4 Eurofins Scientific
    • 11.4.1 Eurofins Scientific Company Details
    • 11.4.2 Eurofins Scientific Business Overview
    • 11.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Introduction
    • 11.4.4 Eurofins Scientific Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.4.5 Eurofins Scientific Recent Developments
  • 11.5 BGI Group
    • 11.5.1 BGI Group Company Details
    • 11.5.2 BGI Group Business Overview
    • 11.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Introduction
    • 11.5.4 BGI Group Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.5.5 BGI Group Recent Developments
  • 11.6 Qiagen
    • 11.6.1 Qiagen Company Details
    • 11.6.2 Qiagen Business Overview
    • 11.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Introduction
    • 11.6.4 Qiagen Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.6.5 Qiagen Recent Developments
  • 11.7 Roche Diagnostics
    • 11.7.1 Roche Diagnostics Company Details
    • 11.7.2 Roche Diagnostics Business Overview
    • 11.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Introduction
    • 11.7.4 Roche Diagnostics Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.7.5 Roche Diagnostics Recent Developments
  • 11.8 Bio-Rad
    • 11.8.1 Bio-Rad Company Details
    • 11.8.2 Bio-Rad Business Overview
    • 11.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Introduction
    • 11.8.4 Bio-Rad Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.8.5 Bio-Rad Recent Developments
  • 11.9 Congenica
    • 11.9.1 Congenica Company Details
    • 11.9.2 Congenica Business Overview
    • 11.9.3 Congenica Clinical Next Generation Sequencing (NGS) Introduction
    • 11.9.4 Congenica Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.9.5 Congenica Recent Developments
  • 11.10 Theragen Etex
    • 11.10.1 Theragen Etex Company Details
    • 11.10.2 Theragen Etex Business Overview
    • 11.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Introduction
    • 11.10.4 Theragen Etex Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.10.5 Theragen Etex Recent Developments
  • 11.11 PerkinElmer
    • 11.11.1 PerkinElmer Company Details
    • 11.11.2 PerkinElmer Business Overview
    • 11.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Introduction
    • 11.11.4 PerkinElmer Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.11.5 PerkinElmer Recent Developments
  • 11.12 Partek
    • 11.12.1 Partek Company Details
    • 11.12.2 Partek Business Overview
    • 11.12.3 Partek Clinical Next Generation Sequencing (NGS) Introduction
    • 11.12.4 Partek Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.12.5 Partek Recent Developments
  • 11.13 Oxford Nanopore Technologies
    • 11.13.1 Oxford Nanopore Technologies Company Details
    • 11.13.2 Oxford Nanopore Technologies Business Overview
    • 11.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Introduction
    • 11.13.4 Oxford Nanopore Technologies Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.13.5 Oxford Nanopore Technologies Recent Developments
  • 11.14 Pacific Biosciences of California
    • 11.14.1 Pacific Biosciences of California Company Details
    • 11.14.2 Pacific Biosciences of California Business Overview
    • 11.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Introduction
    • 11.14.4 Pacific Biosciences of California Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.14.5 Pacific Biosciences of California Recent Developments
  • 11.15 Golden Helix
    • 11.15.1 Golden Helix Company Details
    • 11.15.2 Golden Helix Business Overview
    • 11.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Introduction
    • 11.15.4 Golden Helix Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.15.5 Golden Helix Recent Developments
  • 11.16 BioDatomics
    • 11.16.1 BioDatomics Company Details
    • 11.16.2 BioDatomics Business Overview
    • 11.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Introduction
    • 11.16.4 BioDatomics Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.16.5 BioDatomics Recent Developments
  • 11.17 PierianDx
    • 11.17.1 PierianDx Company Details
    • 11.17.2 PierianDx Business Overview
    • 11.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Introduction
    • 11.17.4 PierianDx Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.17.5 PierianDx Recent Developments
  • 11.18 DNAStar
    • 11.18.1 DNAStar Company Details
    • 11.18.2 DNAStar Business Overview
    • 11.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Introduction
    • 11.18.4 DNAStar Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.18.5 DNAStar Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Sequencing by Synthesis (SBS)
    • 1.2.3 Nanopore Sequencing
    • 1.2.4 Single-Molecule Real-Time (SMRT) Sequencing
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Diagnostics
    • 1.3.3 Drug Discovery & Designing
    • 1.3.4 Medical Research
    • 1.3.5 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Clinical Next Generation Sequencing (NGS) Market Perspective (2018-2029)
  • 2.2 Global Clinical Next Generation Sequencing (NGS) Growth Trends by Region
    • 2.2.1 Clinical Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Clinical Next Generation Sequencing (NGS) Historic Market Size by Region (2018-2023)
    • 2.2.3 Clinical Next Generation Sequencing (NGS) Forecasted Market Size by Region (2024-2029)
  • 2.3 Clinical Next Generation Sequencing (NGS) Market Dynamics
    • 2.3.1 Clinical Next Generation Sequencing (NGS) Industry Trends
    • 2.3.2 Clinical Next Generation Sequencing (NGS) Market Drivers
    • 2.3.3 Clinical Next Generation Sequencing (NGS) Market Challenges
    • 2.3.4 Clinical Next Generation Sequencing (NGS) Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Clinical Next Generation Sequencing (NGS) by Players
    • 3.1.1 Global Clinical Next Generation Sequencing (NGS) Revenue by Players (2018-2023)
    • 3.1.2 Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Players (2018-2023)
  • 3.2 Global Clinical Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Clinical Next Generation Sequencing (NGS), Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Clinical Next Generation Sequencing (NGS) Market Concentration Ratio
    • 3.4.1 Global Clinical Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Clinical Next Generation Sequencing (NGS) Revenue in 2022
  • 3.5 Global Key Players of Clinical Next Generation Sequencing (NGS) Head office and Area Served
  • 3.6 Global Key Players of Clinical Next Generation Sequencing (NGS), Product and Application
  • 3.7 Global Key Players of Clinical Next Generation Sequencing (NGS), Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Clinical Next Generation Sequencing (NGS) Breakdown Data by Type

  • 4.1 Global Clinical Next Generation Sequencing (NGS) Historic Market Size by Type (2018-2023)
  • 4.2 Global Clinical Next Generation Sequencing (NGS) Forecasted Market Size by Type (2024-2029)

5 Clinical Next Generation Sequencing (NGS) Breakdown Data by Application

  • 5.1 Global Clinical Next Generation Sequencing (NGS) Historic Market Size by Application (2018-2023)
  • 5.2 Global Clinical Next Generation Sequencing (NGS) Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 6.2 North America Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 6.2.1 North America Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 6.2.2 North America Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 6.2.3 North America Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 6.3 North America Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 6.3.1 North America Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 6.3.2 North America Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 6.3.3 North America Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • 6.4 North America Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 6.4.1 North America Clinical Next Generation Sequencing (NGS) Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
    • 6.4.3 North America Clinical Next Generation Sequencing (NGS) Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 7.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 7.2.1 Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 7.2.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 7.2.3 Europe Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 7.3 Europe Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 7.3.1 Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 7.3.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 7.3.3 Europe Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • 7.4 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 7.4.1 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
    • 7.4.3 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 8.2 China Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 8.2.1 China Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 8.2.2 China Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 8.2.3 China Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 8.3 China Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 8.3.1 China Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 8.3.2 China Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 8.3.3 China Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 9.2 Asia Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 9.2.1 Asia Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 9.2.2 Asia Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 9.2.3 Asia Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 9.3 Asia Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 9.3.1 Asia Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 9.3.2 Asia Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 9.3.3 Asia Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • 9.4 Asia Clinical Next Generation Sequencing (NGS) Market Size by Region
    • 9.4.1 Asia Clinical Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023)
    • 9.4.3 Asia Clinical Next Generation Sequencing (NGS) Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Agilent Technologies
    • 11.1.1 Agilent Technologies Company Details
    • 11.1.2 Agilent Technologies Business Overview
    • 11.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Introduction
    • 11.1.4 Agilent Technologies Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.1.5 Agilent Technologies Recent Developments
  • 11.2 Illumina
    • 11.2.1 Illumina Company Details
    • 11.2.2 Illumina Business Overview
    • 11.2.3 Illumina Clinical Next Generation Sequencing (NGS) Introduction
    • 11.2.4 Illumina Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.2.5 Illumina Recent Developments
  • 11.3 Thermo Fisher Scientific
    • 11.3.1 Thermo Fisher Scientific Company Details
    • 11.3.2 Thermo Fisher Scientific Business Overview
    • 11.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Introduction
    • 11.3.4 Thermo Fisher Scientific Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.3.5 Thermo Fisher Scientific Recent Developments
  • 11.4 Eurofins Scientific
    • 11.4.1 Eurofins Scientific Company Details
    • 11.4.2 Eurofins Scientific Business Overview
    • 11.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Introduction
    • 11.4.4 Eurofins Scientific Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.4.5 Eurofins Scientific Recent Developments
  • 11.5 BGI Group
    • 11.5.1 BGI Group Company Details
    • 11.5.2 BGI Group Business Overview
    • 11.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Introduction
    • 11.5.4 BGI Group Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.5.5 BGI Group Recent Developments
  • 11.6 Qiagen
    • 11.6.1 Qiagen Company Details
    • 11.6.2 Qiagen Business Overview
    • 11.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Introduction
    • 11.6.4 Qiagen Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.6.5 Qiagen Recent Developments
  • 11.7 Roche Diagnostics
    • 11.7.1 Roche Diagnostics Company Details
    • 11.7.2 Roche Diagnostics Business Overview
    • 11.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Introduction
    • 11.7.4 Roche Diagnostics Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.7.5 Roche Diagnostics Recent Developments
  • 11.8 Bio-Rad
    • 11.8.1 Bio-Rad Company Details
    • 11.8.2 Bio-Rad Business Overview
    • 11.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Introduction
    • 11.8.4 Bio-Rad Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.8.5 Bio-Rad Recent Developments
  • 11.9 Congenica
    • 11.9.1 Congenica Company Details
    • 11.9.2 Congenica Business Overview
    • 11.9.3 Congenica Clinical Next Generation Sequencing (NGS) Introduction
    • 11.9.4 Congenica Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.9.5 Congenica Recent Developments
  • 11.10 Theragen Etex
    • 11.10.1 Theragen Etex Company Details
    • 11.10.2 Theragen Etex Business Overview
    • 11.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Introduction
    • 11.10.4 Theragen Etex Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.10.5 Theragen Etex Recent Developments
  • 11.11 PerkinElmer
    • 11.11.1 PerkinElmer Company Details
    • 11.11.2 PerkinElmer Business Overview
    • 11.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Introduction
    • 11.11.4 PerkinElmer Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.11.5 PerkinElmer Recent Developments
  • 11.12 Partek
    • 11.12.1 Partek Company Details
    • 11.12.2 Partek Business Overview
    • 11.12.3 Partek Clinical Next Generation Sequencing (NGS) Introduction
    • 11.12.4 Partek Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.12.5 Partek Recent Developments
  • 11.13 Oxford Nanopore Technologies
    • 11.13.1 Oxford Nanopore Technologies Company Details
    • 11.13.2 Oxford Nanopore Technologies Business Overview
    • 11.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Introduction
    • 11.13.4 Oxford Nanopore Technologies Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.13.5 Oxford Nanopore Technologies Recent Developments
  • 11.14 Pacific Biosciences of California
    • 11.14.1 Pacific Biosciences of California Company Details
    • 11.14.2 Pacific Biosciences of California Business Overview
    • 11.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Introduction
    • 11.14.4 Pacific Biosciences of California Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.14.5 Pacific Biosciences of California Recent Developments
  • 11.15 Golden Helix
    • 11.15.1 Golden Helix Company Details
    • 11.15.2 Golden Helix Business Overview
    • 11.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Introduction
    • 11.15.4 Golden Helix Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.15.5 Golden Helix Recent Developments
  • 11.16 BioDatomics
    • 11.16.1 BioDatomics Company Details
    • 11.16.2 BioDatomics Business Overview
    • 11.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Introduction
    • 11.16.4 BioDatomics Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.16.5 BioDatomics Recent Developments
  • 11.17 PierianDx
    • 11.17.1 PierianDx Company Details
    • 11.17.2 PierianDx Business Overview
    • 11.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Introduction
    • 11.17.4 PierianDx Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.17.5 PierianDx Recent Developments
  • 11.18 DNAStar
    • 11.18.1 DNAStar Company Details
    • 11.18.2 DNAStar Business Overview
    • 11.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Introduction
    • 11.18.4 DNAStar Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
    • 11.18.5 DNAStar Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

List of Tables

  • Table 1. Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Sequencing by Synthesis (SBS)
  • Table 3. Key Players of Nanopore Sequencing
  • Table 4. Key Players of Single-Molecule Real-Time (SMRT) Sequencing
  • Table 5. Key Players of Others
  • Table 6. Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 7. Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 8. Global Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & (US$ Million)
  • Table 9. Global Clinical Next Generation Sequencing (NGS) Market Share by Region (2018-2023)
  • Table 10. Global Clinical Next Generation Sequencing (NGS) Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 11. Global Clinical Next Generation Sequencing (NGS) Market Share by Region (2024-2029)
  • Table 12. Clinical Next Generation Sequencing (NGS) Market Trends
  • Table 13. Clinical Next Generation Sequencing (NGS) Market Drivers
  • Table 14. Clinical Next Generation Sequencing (NGS) Market Challenges
  • Table 15. Clinical Next Generation Sequencing (NGS) Market Restraints
  • Table 16. Global Clinical Next Generation Sequencing (NGS) Revenue by Players (2018-2023) & (US$ Million)
  • Table 17. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Players (2018-2023)
  • Table 18. Global Top Clinical Next Generation Sequencing (NGS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next Generation Sequencing (NGS) as of 2022)
  • Table 19. Global Clinical Next Generation Sequencing (NGS) Industry Ranking 2021 VS 2022 VS 2023
  • Table 20. Global 5 Largest Players Market Share by Clinical Next Generation Sequencing (NGS) Revenue (CR5 and HHI) & (2018-2023)
  • Table 21. Global Key Players of Clinical Next Generation Sequencing (NGS), Headquarters and Area Served
  • Table 22. Global Key Players of Clinical Next Generation Sequencing (NGS), Product and Application
  • Table 23. Global Key Players of Clinical Next Generation Sequencing (NGS), Product and Application
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
  • Table 26. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Type (2018-2023)
  • Table 27. Global Clinical Next Generation Sequencing (NGS) Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 28. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Type (2024-2029)
  • Table 29. Global Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
  • Table 30. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Application (2018-2023)
  • Table 31. Global Clinical Next Generation Sequencing (NGS) Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 32. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Application (2024-2029)
  • Table 33. North America Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
  • Table 34. North America Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029) & (US$ Million)
  • Table 35. North America Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
  • Table 36. North America Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029) & (US$ Million)
  • Table 37. North America Clinical Next Generation Sequencing (NGS) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 38. North America Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
  • Table 39. North America Clinical Next Generation Sequencing (NGS) Market Size by Country (2024-2029) & (US$ Million)
  • Table 40. Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
  • Table 41. Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029) & (US$ Million)
  • Table 42. Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
  • Table 43. Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029) & (US$ Million)
  • Table 44. Europe Clinical Next Generation Sequencing (NGS) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 45. Europe Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
  • Table 46. Europe Clinical Next Generation Sequencing (NGS) Market Size by Country (2024-2029) & (US$ Million)
  • Table 47. China Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
  • Table 48. China Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029) & (US$ Million)
  • Table 49. China Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
  • Table 50. China Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029) & (US$ Million)
  • Table 51. Asia Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
  • Table 52. Asia Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029) & (US$ Million)
  • Table 53. Asia Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
  • Table 54. Asia Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029) & (US$ Million)
  • Table 55. Asia Clinical Next Generation Sequencing (NGS) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 56. Asia Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & (US$ Million)
  • Table 57. Asia Clinical Next Generation Sequencing (NGS) Market Size by Region (2024-2029) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 63. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & (US$ Million)
  • Table 64. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size by Country (2024-2029) & (US$ Million)
  • Table 65. Agilent Technologies Company Details
  • Table 66. Agilent Technologies Business Overview
  • Table 67. Agilent Technologies Clinical Next Generation Sequencing (NGS) Product
  • Table 68. Agilent Technologies Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 69. Agilent Technologies Recent Developments
  • Table 70. Illumina Company Details
  • Table 71. Illumina Business Overview
  • Table 72. Illumina Clinical Next Generation Sequencing (NGS) Product
  • Table 73. Illumina Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 74. Illumina Recent Developments
  • Table 75. Thermo Fisher Scientific Company Details
  • Table 76. Thermo Fisher Scientific Business Overview
  • Table 77. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product
  • Table 78. Thermo Fisher Scientific Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 79. Thermo Fisher Scientific Recent Developments
  • Table 80. Eurofins Scientific Company Details
  • Table 81. Eurofins Scientific Business Overview
  • Table 82. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product
  • Table 83. Eurofins Scientific Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 84. Eurofins Scientific Recent Developments
  • Table 85. BGI Group Company Details
  • Table 86. BGI Group Business Overview
  • Table 87. BGI Group Clinical Next Generation Sequencing (NGS) Product
  • Table 88. BGI Group Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 89. BGI Group Recent Developments
  • Table 90. Qiagen Company Details
  • Table 91. Qiagen Business Overview
  • Table 92. Qiagen Clinical Next Generation Sequencing (NGS) Product
  • Table 93. Qiagen Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 94. Qiagen Recent Developments
  • Table 95. Roche Diagnostics Company Details
  • Table 96. Roche Diagnostics Business Overview
  • Table 97. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product
  • Table 98. Roche Diagnostics Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 99. Roche Diagnostics Recent Developments
  • Table 100. Bio-Rad Company Details
  • Table 101. Bio-Rad Business Overview
  • Table 102. Bio-Rad Clinical Next Generation Sequencing (NGS) Product
  • Table 103. Bio-Rad Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 104. Bio-Rad Recent Developments
  • Table 105. Congenica Company Details
  • Table 106. Congenica Business Overview
  • Table 107. Congenica Clinical Next Generation Sequencing (NGS) Product
  • Table 108. Congenica Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 109. Congenica Recent Developments
  • Table 110. Theragen Etex Company Details
  • Table 111. Theragen Etex Business Overview
  • Table 112. Theragen Etex Clinical Next Generation Sequencing (NGS) Product
  • Table 113. Theragen Etex Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 114. Theragen Etex Recent Developments
  • Table 115. PerkinElmer Company Details
  • Table 116. PerkinElmer Business Overview
  • Table 117. PerkinElmer Clinical Next Generation Sequencing (NGS) Product
  • Table 118. PerkinElmer Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 119. PerkinElmer Recent Developments
  • Table 120. Partek Company Details
  • Table 121. Partek Business Overview
  • Table 122. Partek Clinical Next Generation Sequencing (NGS) Product
  • Table 123. Partek Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 124. Partek Recent Developments
  • Table 125. Oxford Nanopore Technologies Company Details
  • Table 126. Oxford Nanopore Technologies Business Overview
  • Table 127. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product
  • Table 128. Oxford Nanopore Technologies Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 129. Oxford Nanopore Technologies Recent Developments
  • Table 130. Pacific Biosciences of California Company Details
  • Table 131. Pacific Biosciences of California Business Overview
  • Table 132. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product
  • Table 133. Pacific Biosciences of California Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 134. Pacific Biosciences of California Recent Developments
  • Table 135. Golden Helix Company Details
  • Table 136. Golden Helix Business Overview
  • Table 137. Golden Helix Clinical Next Generation Sequencing (NGS) Product
  • Table 138. Golden Helix Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 139. Golden Helix Recent Developments
  • Table 140. BioDatomics Company Details
  • Table 141. BioDatomics Business Overview
  • Table 142. BioDatomics Clinical Next Generation Sequencing (NGS) Product
  • Table 143. BioDatomics Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 144. BioDatomics Recent Developments
  • Table 145. PierianDx Company Details
  • Table 146. PierianDx Business Overview
  • Table 147. PierianDx Clinical Next Generation Sequencing (NGS) Product
  • Table 148. PierianDx Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 149. PierianDx Recent Developments
  • Table 150. DNAStar Company Details
  • Table 151. DNAStar Business Overview
  • Table 152. DNAStar Clinical Next Generation Sequencing (NGS) Product
  • Table 153. DNAStar Revenue in Clinical Next Generation Sequencing (NGS) Business (2018-2023) & (US$ Million)
  • Table 154. DNAStar Recent Developments
  • Table 155. Research Programs/Design for This Report
  • Table 156. Key Data Information from Secondary Sources
  • Table 157. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Clinical Next Generation Sequencing (NGS) Market Share by Type: 2022 VS 2029
  • Figure 3. Sequencing by Synthesis (SBS) Features
  • Figure 4. Nanopore Sequencing Features
  • Figure 5. Single-Molecule Real-Time (SMRT) Sequencing Features
  • Figure 6. Others Features
  • Figure 7. Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 8. Global Clinical Next Generation Sequencing (NGS) Market Share by Application: 2022 VS 2029
  • Figure 9. Diagnostics Case Studies
  • Figure 10. Drug Discovery & Designing Case Studies
  • Figure 11. Medical Research Case Studies
  • Figure 12. Others Case Studies
  • Figure 13. Clinical Next Generation Sequencing (NGS) Report Years Considered
  • Figure 14. Global Clinical Next Generation Sequencing (NGS) Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 15. Global Clinical Next Generation Sequencing (NGS) Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 16. Global Clinical Next Generation Sequencing (NGS) Market Share by Region: 2022 VS 2029
  • Figure 17. Global Clinical Next Generation Sequencing (NGS) Market Share by Players in 2022
  • Figure 18. Global Top Clinical Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next Generation Sequencing (NGS) as of 2022)
  • Figure 19. The Top 10 and 5 Players Market Share by Clinical Next Generation Sequencing (NGS) Revenue in 2022
  • Figure 20. North America Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 21. North America Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • Figure 22. North America Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • Figure 23. North America Clinical Next Generation Sequencing (NGS) Market Share by Country (2018-2029)
  • Figure 24. United States Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Canada Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Europe Clinical Next Generation Sequencing (NGS) Market Size YoY (2018-2029) & (US$ Million)
  • Figure 27. Europe Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • Figure 28. Europe Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • Figure 29. Europe Clinical Next Generation Sequencing (NGS) Market Share by Country (2018-2029)
  • Figure 30. Germany Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. France Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. U.K. Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Italy Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Russia Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Nordic Countries Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. China Clinical Next Generation Sequencing (NGS) Market Size YoY (2018-2029) & (US$ Million)
  • Figure 37. China Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • Figure 38. China Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • Figure 39. Asia Clinical Next Generation Sequencing (NGS) Market Size YoY (2018-2029) & (US$ Million)
  • Figure 40. Asia Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • Figure 41. Asia Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • Figure 42. Asia Clinical Next Generation Sequencing (NGS) Market Share by Region (2018-2029)
  • Figure 43. Japan Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. South Korea Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. China Taiwan Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. India Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. Australia Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 49. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Size YoY (2018-2029) & (US$ Million)
  • Figure 50. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Share by Type (2018-2029)
  • Figure 51. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Share by Application (2018-2029)
  • Figure 52. Middle East, Africa, and Latin America Clinical Next Generation Sequencing (NGS) Market Share by Country (2018-2029)
  • Figure 53. Brazil Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Mexico Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Turkey Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Saudi Arabia Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Israel Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 58. GCC Countries Clinical Next Generation Sequencing (NGS) Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 59. Agilent Technologies Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 60. Illumina Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 62. Eurofins Scientific Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 63. BGI Group Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 64. Qiagen Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 65. Roche Diagnostics Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 66. Bio-Rad Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 67. Congenica Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 68. Theragen Etex Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 69. PerkinElmer Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 70. Partek Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 71. Oxford Nanopore Technologies Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 72. Pacific Biosciences of California Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 73. Golden Helix Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 74. BioDatomics Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 75. PierianDx Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 76. DNAStar Revenue Growth Rate in Clinical Next Generation Sequencing (NGS) Business (2018-2023)
  • Figure 77. Bottom-up and Top-down Approaches for This Report
  • Figure 78. Data Triangulation
  • Figure 79. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!